0000932799-05-000115.txt : 20120613
0000932799-05-000115.hdr.sgml : 20120613
20050329161929
ACCESSION NUMBER: 0000932799-05-000115
CONFORMED SUBMISSION TYPE: SC 13D/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20050329
DATE AS OF CHANGE: 20050329
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: SAFETY COMPONENTS INTERNATIONAL INC
CENTRAL INDEX KEY: 0000918964
STANDARD INDUSTRIAL CLASSIFICATION: MOTOR VEHICLE PARTS & ACCESSORIES [3714]
IRS NUMBER: 330596831
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13D/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-45337
FILM NUMBER: 05709954
BUSINESS ADDRESS:
STREET 1: 41 STEVENS STREET
CITY: GREENVILLE
STATE: SC
ZIP: 29605
BUSINESS PHONE: 8642402709
MAIL ADDRESS:
STREET 1: 41 STEVENS STREET
CITY: GREENVILLE
STATE: SC
ZIP: 29605
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: MELLON HBV ALTERNATIVE STRATEGIES LLC
CENTRAL INDEX KEY: 0001218315
IRS NUMBER: 134050836
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13D/A
BUSINESS ADDRESS:
STREET 1: 200 PARK AVE
STREET 2: STE 3300
CITY: NEW YORK
STATE: NY
ZIP: 10166-3399
BUSINESS PHONE: 2128083941
MAIL ADDRESS:
STREET 1: 200 PARK AVE
STREET 2: STE 3300
CITY: NEW YORK
STATE: NY
ZIP: 10166-3399
SC 13D/A
1
safety13da.txt
AMENDMENT NO. 1 TO SC 13D
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)
--------
Safety Components International, Inc.
-------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.01 par value
-------------------------------------------------------------------------------
(Title of Class of Securities)
786474205
-------------------------------------------------------------------------------
(CUSIP Number)
Mellon HBV Alternative Investment Strategies LLC
200 Park Avenue, Suite 3300
New York, NY 10166-3399
(212) 808-3950
-------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
November 30, 2004
-------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box. Note: Schedules filed in paper format shall include a signed
original and five copies of the schedule, including all exhibits. See Rule
13d-7(b) for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
CUSIP NO. 786474205
-----------------------------------------------------------------------
1 NAME OF REPORTING PERSON.
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
Mellon HBV Alternative Strategies LLC
I.R.S. No.: 13-4050836
-----------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see Instructions)
(a) (b)
-----------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------
4 SOURCE OF FUNDS
OO
------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e)
------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
------------------------------------------------------------------------
7 SOLE VOTING POWER
358,606
------------------------------------------------------------------------
8 SHARED VOTING POWER
0
------------------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
358,606
------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
-----------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
358,606
-----------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES (see Instructions)
-----------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
6.7%
-----------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (see Instructions)
IA
-----------------------------------------------------------------------
Introduction: As further described in this Amendment No. 1 to Schedule 13D,
the Reporting Person beneficially owns for investment purposes approximately
6.7% of the Common Stock of Safety Components International, Inc. (the
"Company").
Item 1. Security and Issuer
Security: Common Stock, $0.01 par value per share ("Common Stock").
Issuer's Name and Address: Safety Components International, Inc., 41
Stevens Street, Greenville, SC 29605.
Item 2. Identity and Background
(a) Mellon HBV Alternative Investment Strategies LLC (the "Reporting
Person").
(b) The Reporting Person is a Delaware limited liability company with its
principal executive offices located at 200 Park Avenue, Suite 3300, New York, NY
10166-3399.
(c) The Reporting Person serves as investment advisor of Mellon HBV Master
Multi-Strategy Fund LP, Mellon HBV Master Leveraged Multi-Strategy Fund LP and
Mellon HBV Master US Event Driven Fund LP (collectively, the "Clients"). None of
the Clients individually owns more than 5% but the Clients collectively hold the
Shares.
(d) During the last five years neither the Reporting Person, nor, to the
best of its knowledge, any of its directors or executive officers, has been (i)
convicted of any criminal proceeding (excluding traffic violations or similar
misdemeanors) or (ii) a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction and as a result of such proceeding
was or is subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to federal or
state securities laws or finding any violation with respect to such laws.
Item 3. Source and Amount of Funds or Other Consideration
The Reporting Person used funds from the working capital of the Clients
allocated by such Clients to the Reporting Person for purposes of effecting
investment transactions. The Reporting Person used an aggregate of $669,909.84
to acquire the Shares reported herein as being acquired in the past 60 days. The
Reporting Person borrowed no funds to purchase any of the Shares.
Item 4. Purpose of Transaction
The Reporting Person acquired Common Stock of the Company for investment
purposes. The Reporting Person may at any time increase or decrease its position
in the securities of the Company. At the present time, the Reporting Person has
no intention to effect any of the transactions specified in the instructions to
Item 4 of the of Schedule 13D.
Item 5. Interest in Securities of the Issuer
(a) As of March 28 2005, the Reporting Person beneficially owned in the
aggregate 358,606 shares of the Company's Common Stock (the "Shares"),
representing approximately 6.7% of the outstanding Common Stock (based on the
number of shares outstanding as of March 1, 2005 as reported in the Company's
quarterly report on Form 10-K for the fiscal year ended December 31, 2004).
(b) The Reporting Person has the sole power to vote or to direct the vote
and the sole power to dispose and to direct the disposition of the Shares.
(c) Information relating to the transactions effected by the Reporting
Person with respect to the Company's Common Stock in the past sixty (60) days is
set forth in Exhibit A attached hereto.
(d) Not applicable.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with
Respect to Securities of the Issuer
None.
Item 7. Material to be Filed as Exhibits
Exhibit A: Table containing information with respect to open-market
transactions in the Common Stock of the Company effected by Reporting Person
during the past sixty (60) days.
Signature After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: March 29, 2005
Mellon HBV Alternative Strategies LLC,
a Delaware Limited Liability Company
By: /s/ William F. Harley III
--------------------------------
William F. Harley III
President and Chief Executive Officer
Exhibit A
Information with Respect to Open-Market Transactions in the Common Stock of
the Company effected by the Reporting Person during the Past Sixty (60) Days
-----------------------------------------------------------------------------
Type of No. of Average
Trade Date Transaction Shares Price per Share
-----------------------------------------------------------------------------
-------------------------------------------------------------------------
March 15, 2005 Buy 100 $17.45
-------------------------------------------------------------------------
March 18, 2005 Buy 200 $17.50
-------------------------------------------------------------------------
March 23, 2005 Buy 700 $17.00
-------------------------------------------------------------------------
March 24, 2005 Buy 3,000 $16.04
-------------------------------------------------------------------------
March 24, 2005 Buy 15,000 $16.25
-------------------------------------------------------------------------
March 24, 2005 Buy 21,800 $16.17
-------------------------------------------------------------------------
March 28, 2005 Buy 200 $16.50
-------------------------------------------------------------------------